IL103855A - 5,6-דיהידרו-דיבנז]b,e[אזפין-6,11- דיון-11-אוקסימים, הכנתם ותכשירי רוקחות המכילים אותם - Google Patents

5,6-דיהידרו-דיבנז]b,e[אזפין-6,11- דיון-11-אוקסימים, הכנתם ותכשירי רוקחות המכילים אותם

Info

Publication number
IL103855A
IL103855A IL10385592A IL10385592A IL103855A IL 103855 A IL103855 A IL 103855A IL 10385592 A IL10385592 A IL 10385592A IL 10385592 A IL10385592 A IL 10385592A IL 103855 A IL103855 A IL 103855A
Authority
IL
Israel
Prior art keywords
carbon atoms
chain
straight
general formula
compounds
Prior art date
Application number
IL10385592A
Other languages
English (en)
Other versions
IL103855A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL103855A0 publication Critical patent/IL103855A0/xx
Publication of IL103855A publication Critical patent/IL103855A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10385592A 1991-11-27 1992-11-24 5,6-דיהידרו-דיבנז]b,e[אזפין-6,11- דיון-11-אוקסימים, הכנתם ותכשירי רוקחות המכילים אותם IL103855A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4138853A DE4138853A1 (de) 1991-11-27 1991-11-27 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11- oxime

Publications (2)

Publication Number Publication Date
IL103855A0 IL103855A0 (en) 1993-04-04
IL103855A true IL103855A (he) 1996-09-12

Family

ID=6445615

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10385592A IL103855A (he) 1991-11-27 1992-11-24 5,6-דיהידרו-דיבנז]b,e[אזפין-6,11- דיון-11-אוקסימים, הכנתם ותכשירי רוקחות המכילים אותם

Country Status (16)

Country Link
US (1) US5416209A (he)
EP (1) EP0544171B1 (he)
JP (1) JPH05246996A (he)
KR (1) KR100234924B1 (he)
AT (1) ATE114115T1 (he)
AU (1) AU650800B2 (he)
CA (1) CA2083798A1 (he)
DE (2) DE4138853A1 (he)
DK (1) DK0544171T3 (he)
ES (1) ES2063562T3 (he)
GR (1) GR3014990T3 (he)
HU (2) HU9203732D0 (he)
IL (1) IL103855A (he)
NZ (1) NZ245263A (he)
TW (1) TW325469B (he)
ZA (1) ZA929175B (he)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
DE4138908A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 6-thiono-dibenz(b,e)azepine
CN102153513B (zh) * 2011-02-28 2012-05-30 中国农业大学 烃氧亚氨基二苯并己内酰胺衍生物及其制备方法与作为杀菌剂的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545856A1 (de) * 1965-09-10 1969-11-27 Bayer Ag Verfahren zur Herstellung von basisch substituierten Derivaten des 5,6-Dihydro-dibenz-[b,e]-azepin-6,11-dion-11-oxims
GB1132516A (en) * 1966-02-01 1968-11-06 Ici Ltd Morphanthridine derivatives
IT1207417B (it) * 1982-03-15 1989-05-17 Menarini Sas Azepina-6-one ad attivita'composti triciclici derivati dalla farmacologica, e procedimenti di 5,6-diidro-11h-dibenzo (b,e)fabbricazione relativi
ATE129637T1 (de) * 1989-08-29 1995-11-15 Boehringer Ingelheim Pharma Verwendung von dibenzo(b,f>(1,4>oxazepin (und thiazepin)-11(10h)-one und -thione zur herstellung eines arzneimittels zur prävention und behandlung von aids.
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection

Also Published As

Publication number Publication date
CA2083798A1 (en) 1993-05-28
DE4138853A1 (de) 1993-06-03
DE59200789D1 (de) 1994-12-22
KR100234924B1 (ko) 1999-12-15
NZ245263A (en) 1997-05-26
IL103855A0 (en) 1993-04-04
US5416209A (en) 1995-05-16
ATE114115T1 (de) 1994-12-15
ZA929175B (en) 1993-05-25
HUT65451A (en) 1994-06-28
KR930010002A (ko) 1993-06-21
EP0544171B1 (de) 1994-11-17
TW325469B (en) 1998-01-21
AU650800B2 (en) 1994-06-30
GR3014990T3 (en) 1995-05-31
HU9203732D0 (en) 1993-03-29
AU2859792A (en) 1993-06-03
JPH05246996A (ja) 1993-09-24
ES2063562T3 (es) 1995-01-01
EP0544171A1 (de) 1993-06-02
DK0544171T3 (da) 1995-05-01

Similar Documents

Publication Publication Date Title
KR100494214B1 (ko) 삼환화합물,그의제조방법및용도
US20020128208A1 (en) Nonpeptide agonists and antagonists of vasopressin receptors
EP2872502B1 (en) Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
IE861015L (en) Triazoles
IL103855A (he) 5,6-דיהידרו-דיבנז]b,e[אזפין-6,11- דיון-11-אוקסימים, הכנתם ותכשירי רוקחות המכילים אותם
EA001389B1 (ru) Антивирусные соединения
EP1089979A1 (en) Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
WO2000023437A1 (fr) Composes azotes hererocycliques condenses; procede de fabrication et agents les renfermant
US5385899A (en) Aminoalkyl-substituted 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
HU218209B (hu) 2,3-Ciklikusan kondenzált 1,4-dihidro-piridin-származékok alkalmazása a központi idegrendszer kezelésére alkalmas gyógyszerkészítmények előállítására
US5545736A (en) 6-thiono-5,6-dihydro-dibenz[B,E] azepin-11-one-11-oximes
US20040063699A1 (en) Gpr14 antagonist
US6649761B2 (en) Process for preparing piperazinepentaneamide HIV protease inhibitors
JP3749275B2 (ja) オキサゼピノピリドインドール誘導体及びその製造方法
KR0120278B1 (ko) 7-(4-아미노-3-옥심)피롤리딘 치환체를 갖는 신규 퀴놀린 카르복실산 유도체 및 그의 제조방법
EP0246633A1 (en) Trans-benzopyran-[4,3-b]-1,4-oxazine derivatives
EP0437382A1 (fr) Nouveaux dérivés de la thymidine leur préparation et les compositions qui les contiennent
JP2002097142A (ja) Gpr14拮抗剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force